Deepak Nitrite Arm Fuels Expansion with ₹150 Cr Infusion

Deepak Nitrite Limited's wholly-owned subsidiary, Deepak Phenolics Limited (DPL), is injecting ₹150 crore into another subsidiary, Deepak Chem Tech Limited (DCTL). The investment involves subscribing to 1.50 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) in DCTL. The planned allotment date for these shares is April 30, 2026.

The funds are earmarked to bolster DCTL's capital base, support its ongoing project expenses, and meet general corporate needs. This strategic move is conducted on an 'arms length' basis and does not require governmental or regulatory approvals.

For context, DCTL reported a turnover of ₹9.43 crore in FY2024-25 and ₹0.86 crore in FY2023-24.

Strategic Importance for Polycarbonate

This capital infusion is critical for DCTL's ambitious expansion into advanced chemical manufacturing, particularly its integrated Polycarbonate (PC) value chain. The funds will enable DCTL to accelerate its large-scale projects, which include developing substantial capacities for Phenol, Acetone, and Isopropyl Alcohol (IPA) – essential raw materials for PC production. This move underscores Deepak Nitrite's commitment to its long-term strategic goals, including import substitution and strengthening domestic supply chains.

Company and Project Background

Deepak Nitrite Limited (DNL) is an established Indian chemical manufacturer with diverse offerings. Its subsidiary, DCTL, is actively developing several major projects in Gujarat. These include a greenfield initiative to build capacities for Phenol (300 KTA), Acetone (185 KTA), and IPA (100 KTA), a project estimated at around ₹3,500 crore aimed at backward integration for PC resin production. DCTL has also acquired a PC plant from Germany and commissioned a Nitration and Hydrogenation plant in Dahej.

The current ₹150 crore investment follows a previous infusion of ₹48 crore via OCRPS to DCTL from DPL in September 2025. DNL's group-wide capital expenditure plans are substantial, with significant outlays planned for PC, Phenol, Acetone, and IPA over the coming years.

Key Impacts of the Infusion

The investment is set to significantly enhance DCTL's financial resources, enabling it to execute its large-scale, capital-intensive projects more effectively. This infusion is expected to accelerate the development and construction timelines for DCTL's planned Phenol, Acetone, IPA, and Polycarbonate facilities. Furthermore, it reinforces Deepak Nitrite's strategy to integrate its value chain and establish a strong presence in the polycarbonate market. With enhanced financial backing, DCTL will be better positioned to manage project expenses and general corporate needs as it prepares for new plant commissioning.

Potential Risks and Challenges

Investors will be monitoring several potential risks. Deepak Phenolics Limited (DPL) faces a ₹2.15 crore penalty from Gujarat GST authorities related to ineligible Input Tax Credit, with an order dated March 6, 2026; DPL plans to appeal this order. The timely and cost-effective execution of DCTL's ambitious, large-scale projects also presents execution risk, given the substantial overall capital expenditure planned by DNL. Additionally, Deepak Nitrite's Nandesari plant previously faced a ₹1 crore fine from GPCB in June 2022 following a fire incident and environmental non-compliance.

Competitive Landscape

Deepak Nitrite operates in a competitive chemical landscape. Key peers include Aarti Industries, known for its diversified speciality chemicals and intermediates; Gujarat Fluorochemicals and Navin Fluorine, which specialize in fluorochemicals relevant to DCTL's operations; and SRF Limited, also a significant player in fluorochemicals and specialty chemicals. DCTL's focus on integrated PC production and specialized chemicals positions it within a segment that requires significant R&D and capital investment.

Investor Outlook

Key areas for investors to track include:

• Progress and commissioning timelines for DCTL's Phenol, Acetone, IPA, and Polycarbonate projects.
• DCTL's financial health and revenue generation once new capacities are operational.
• The outcome of DPL's appeal against the GST penalty.
• The company's leverage and debt servicing capabilities as DCTL undertakes large projects funded partly by debt.
• Market demand trends for Polycarbonate resins and related chemicals in India and globally.